NFKB1 and diabetes mellitus: For instance, and based on this approach, we have already developed in vivo approaches to prevent experimental diabetes by blocking NF-κB [11] and STAT-1 [52] and identified several interesting targets for beta-cell imaging (Flamez D, Kutlu B, Goodman N and Eizirik DL, unpublished data).